ABSTRACT
En este trabajo se hacen algunas consideraciones sobre la memoria y el olvido, se describen complejos procesos emocionales individuales y familiares que dan lugar a determinados estados psicológicos colectivos que suelen configurarse bajo las dictaduras y los estados totalitarios. Reflexiones que se enmarcan en el contexto de la reciente historia de España y que ayudarán a comprender, al menos en parte, el enorme retraso que la recuperación de la memoria ha tenido en nuestro país. Estas aportaciones están apoyadas en fuentes históricas, sociológicas, literarias y basadas en la teoría y la práctica clínica psicológica aplicada a tratamientos individuales, de familia y de grupos. (AU)
In this work, some considerations are made about memory and forgetting, complex individual and family emotional processes that give rise to certain collective psychological states that are usually configured under dictatorships and totalitarian states are described. These reflections are framed in the context of Spains recent history and will help to understand, at least in part, the enormous delay that the recovery of memory has had in our country. These contributions are supported by historical, sociological, and literary sources and based on psychological theory and clinical practice applied to individual, family, and group treatments. (AU)
Subject(s)
History, 20th Century , Memory , Psychology , SpainABSTRACT
En este trabajo se hacen algunas consideraciones sobre la memoria y el olvido, se describen complejos procesos emocionales individuales y familiares que dan lugar a determinados estados psicológicos colectivos que suelen configurarse bajo las dictaduras y los estados totalitarios. Reflexiones que se enmarcan en el contexto de la reciente historia de España y que ayudarán a comprender, al menos en parte, el enorme retraso que la recuperación de la memoria ha tenido en nuestro país. Estas aportaciones están apoyadas en fuentes históricas, sociológicas, literarias y basadas en la teoría y la práctica clínica psicológica aplicada a tratamientos individuales, de familia y de grupos. (AU)
In this work, some considerations are made about memory and forgetting, complex individual and family emotional processes that give rise to certain collective psychological states that are usually configured under dictatorships and totalitarian states are described. These reflections are framed in the context of Spains recent history and will help to understand, at least in part, the enormous delay that the recovery of memory has had in our country. These contributions are supported by historical, sociological, and literary sources and based on psychological theory and clinical practice applied to individual, family, and group treatments. (AU)
Subject(s)
History, 20th Century , Memory , Psychology , SpainABSTRACT
Introducción: En Uruguay el cáncer de mama (CM) ocupa el primer lugar en incidencia y mortalidad por cáncer en la mujer, se trata de una enfermedad multifactorial que guarda relación con la herencia genética, historial hormonal estrogénico, estilo de vida, factores ambientales y culturales. Objetivos: investigar las características clínico-patológicas de pacientes con CM diagnosticadas en el Hospital de Clínicas y evaluar la sobrevida global total (SVG) y de acuerdo al subtipo biológico. Metodología: se recolectaron datos relacionados con las características clínico-patológicas y la evolución de pacientes tratadas por CM en el período comprendido entre el 1º de enero del 2011 y 31 de diciembre de 2020 asistidas en la Unidad de Mastología del Hospital de Clínicas. Se calculó la SVG para todas las pacientes, globalmente, y según el subtipo biológico. Resultados: se incluyeron 390 pacientes. Las características clínico-patológicas fueron: carcinoma ductal: 83%, estadio: in situ (1.8 %), I (27.7 %), II (29.7 %), III (23.6%), IV (12.6 %). Con respecto al perfil biológico: 235 tumores (60.3%) fueron RRHH+ HER 2−, 88 tumores (22.6%) fueron HER2 +, mientras que otros 41 tumores (10.5%) fueron clasificados como triple negativos (TN). La SVG para la totalidad de las pacientes tuvo una mediana de 92 meses. Las tasas de SVG a 2 y 5 años fueron para las luminales de 92% y 64%; en las TN la tasa de SVG a 24 meses fue de 69%, siendo a 5 años de 53.3% y en las HER2 + 76.6% y 67.3% respectivamente. Conclusiones: La mayoría de los tumores fueron diagnosticados en estadios precoces, siendo estos datos son concordantes con los reportados en estudios realizados a nivel nacional. La frecuencia de tumores RE/RP+ algo inferior a la reportada en estudios previos (70%) a nivel nacional, mientras que la de tumores HER 2 + TN fue similar a la reportada en estudios europeos, norteamericanos y en Latinoamérica donde se la prevalencia encontrada es del 20%
Introduction: In Uruguay, breast cancer (BC) ranks first in incidence and mortality from cancer in women. It is a multifactorial disease that is related to genetic inheritance, estrogenic hormonal history, lifestyle, environmental and cultural factors. Objectives: to investigate the clinicopathological characteristics of patients with BC diagnosed at the Hospital de Clínicas and to evaluate the overall overall survival (SVG) and according to the biological subtype. Metodology: data related to the clinicopathological characteristics and the evolution of patients treated for BC in the period between January 1, 2011 and December 31, 2020 assisted in the Mastology Unit of the Hospital de Clínicas were collected. Overall survival (SVG) was calculated for all patients, globally, and according to biological subtype. Results: 390 patients were included. The clinicopathological characteristics were: ductal carcinoma: 83%, stage: in situ (1.8%), I (27.7%), II (29.7%), III (23.6%), IV (12.6%). Regarding the biological profile: 235 tumors (60.3%) were HR+ HER 2−, 88 tumors (22.6%) were HER2 +, while another 41 tumors (10.5%) were classified as triple negative (TN). The SVG for all the patients had a median of 92 months. SVG rates at 2 and 5 years were 92% and 64% for luminals; in TN the 24-month survival rate was 69%, being 53.3% at 5 years and in HER2 + 76.6% and 67.3% respectively. Conclusions: Most of the tumors were diagnosed in early stages, these data being consistent with those reported in studies carried out at the national level. The frequency of ER/RP+ tumors was somewhat lower than that reported in previous studies (70%) at the national level, while that of HER 2 + TN tumors was similar to that reported in European, North American and Latin American studies where the prevalence found is 20%
Introdução: No Uruguai, o câncer de mama (CM) ocupa o primeiro lugar em incidência e mortalidade por câncer em mulheres. É uma doença multifatorial que está relacionada à herança genética, história hormonal estrogênica, estilo de vida, fatores ambientais e culturais. Objetivos: investigar as características clinicopatológicas dos pacientes com CM diagnosticados no Hospital de Clínicas e avaliar a sobrevida global (OSV) e segundo o subtipo biológico. Material e método: foram coletados dados referentes às características clínico-patológicas e à evolução dos pacientes atendidos por CM no período de 1º de janeiro de 2011 a 31 de dezembro de 2020 atendidos na Unidade de Mastologia do Hospital de Clínicas. A sobrevida global (SVG) foi calculada para todos os pacientes, globalmente e de acordo com o subtipo biológico. Resultados: 390 pacientes foram incluídos. As características clínico-patológicas foram: carcinoma ductal: 83%, estádio: in situ (1,8%), I (27,7%), II (29,7%), III (23,6%), IV (12,6%). Quanto ao perfil biológico: 235 tumores (60,3%) eram HR+ HER 2−, 88 tumores (22,6%) eram HER2+, enquanto outros 41 tumores (10,5%) foram classificados como triplo negativo (TN). O SVG para todos os pacientes teve uma mediana de 92 meses. As taxas de SVG aos 2 e 5 anos foram de 92% e 64% para luminais; em TN a sobrevida em 24 meses foi de 69%, sendo 53,3% em 5 anos e em HER2 + 76,6% e 67,3%, respectivamente. Conclusões: A maioria dos tumores foi diagnosticada em estágios iniciais, sendo esses dados consistentes com os relatados em estudos realizados em nível nacional. A frequência de tumores ER/RP+ foi um pouco menor do que a relatada em estudos anteriores (70%) em nível nacional, enquanto a de tumores HER 2 + TN foi semelhante à relatada em estudos europeus, norte-americanos e latino-americanos, onde a prevalência encontrado é 20%
ABSTRACT
Mpoxou Varíola M é uma zoonose causada por vírus do gênero Orthopoxvirus, causadores também da varíola comum. É uma doença considerada rara e autolimitada, sendo endêmica em países africanos. Entretanto, no ano de 2022 ganhou destaque devido ao surto global que se iniciou, quando o mundo ainda se recuperava da pandemia da COVID-19. Dessa forma, por se tratar de uma doença emergente, a presente revisão visa pontuar aspectos gerais do que se sabe até o momento sobre a Mpox, desde sua imunopatogenia até as formas atuais de prevenção e cuidados pós-infecção
Mpox or Variola M is a zoonosis caused by viruses of the genus Orthopoxvirus, which also cause smallpox. It is a disease considered rare and self-limiting, being endemic in African countries. However, in 2022, it gained prominence due to the global outbreak that began when the world was still recovering from the COVID-19 pandemic. Thus, as it is an emerging disease, this review aims to point out general aspects of what is known so far about Mpox, from its immunopathogenesis to current forms of prevention and post-infection care
Subject(s)
Humans , Severe Acute Respiratory Syndrome , Mpox (monkeypox) , Viruses , Wounds and Injuries/virology , Smallpox , Delivery of Health CareABSTRACT
A fibromialgia é uma condição crônica de etiologia desconhecida e desvinculada de marcadores laboratoriais específicos para diagnóstico, devido à pobre caracterização da etiopatogenia. Em geral, as alterações comuns à fibromialgia também são observadas em outras condições de dor crônica, tornando a patogênese controversa entre diferentes condições patológicas. A etiologia desconhecida dificulta o diagnóstico e, consequentemente, repercute em um tratamento não tão eficaz de pacientes com fibromialgia. A restauração de desordens sistêmicas confere amplo espectro de possibilidades terapêuticas com potencial de orientar profissionais a estabelecer metas e métodos de avaliação. Diante disso, essa revisão narrativa se volta para debater hipóteses etiológicas e fisiopatológicas no desenvolvimento da fibromialgia.
Fibromyalgia is a chronic condition of unknown etiology unrelated to specific laboratory markers for diagnosis because of poor etiopathogenesis. In general, the changes common to fibromyalgia are also seen in other chronic pain conditions, making the pathogenesis controversial among different pathological conditions. The unknown etiology makes the diagnosis difficult and consequently has repercussions on a not so effective treatment of patients with fibromyalgia. The restoration of systemic disorders provides a wide spectrum of therapeutic possibilities with the potential to guide professionals in establishing goals and evaluation methods. Therefore, this narrative review discusses the etiological and pathophysiological hypotheses involved in the development of fibromyalgia.
Subject(s)
Humans , Female , Signs and Symptoms , DiagnosisABSTRACT
Resumen El carcinoma mucinoso es una estirpe poco frecuente de cáncer de mama, la cual representa menos del 4% de todos los cánceres primarios. Suele presentarse en pacientes postmenopáusicas, alrededor de la séptima década de la vida. Clínicamente se caracteriza por manifestarse como un nódulo palpable, rara vez acompañado de otra sintomatología. Las herramientas de imagen, como la mastografía y el ultrasonido, son fundamentales para su diagnóstico; sin embargo, en algunas situaciones se puede subestimar el diagnóstico dado a las características similares que comparte con otras lesiones benignas. El diagnóstico definitivo se realiza por medio de histopatología. Debido a la rareza de estos tumores, no existe un consenso sobre el tratamiento más adecuado. Muchos autores concuerdan que la intervención quirúrgica continúa siendo la piedra angular, ya que tiene un impacto positivo en la supervivencia y baja incidencia de recurrencias. Esta se puede acompañar posteriormente de terapias endocrinas adyuvantes. Afortunadamente, el pronóstico de este tipo de tumores suele ser favorable, incluso la supervivencia supera el 90% a los 5 años.
Abstract Mucinous carcinoma is a rare type of breast cancer, which represents less than 4% of all primary cancers. It usually occurs in postmenopausal patients, around the seventh decade of life. Clinically, it is characterized by the presence of a palpable nodule, rarely accompanied by other symptoms. Imaging tools, such as mammogram and ultrasound, are essential for its diagnosis, however, in some situations the diagnosis can be underestimated due to the similar characteristics that it shares with other benign lesions. Definitive diagnosis is made by histopathology. Regarding treatment, there is no consensus on the most appropriate, due to the low incidence of these tumors. Many authors agree that surgical intervention continues to be the best option, showing a positive impact on survival and low recurrences. This can be accompanied later by adjuvant endocrine therapies. Fortunately, the prognosis of this type of tumor is usually favorable, even survival exceeds 90% at 5 years.
ABSTRACT
El cistoadenoma apendicular es una neoplasia poco frecuente, que tiene una incidencia de 0,2 % a 0,3 % en todas las apendicetomías; esta afección predomina en pacientes féminas y su presentación es poco específica en cuanto a los síntomas, los cuales pueden compararse a un cuadro de apendicitis aguda, una masa abdominal, un cuadro obstructivo o ginecológico, o manifestaciones urológicas, que son las menos frecuentes. Se presentó una paciente femenina de 59 años de edad con dolor abdominal localizado en la fosa ilíaca derecha de 4 meses de evolución; se realizaron varios exámenes complementarios, una laparoscopia diagnóstica, una laparotomía exploratoria y también una apendicetomía. Después de estos exámenes se realizó un diagnóstico histológico de cistoadenoma mucinoso apendicular.
Appendiceal cystadenoma is a rare neoplasm, with an incidence of 0.2% to 0.3% among all appendectomies; this condition predominates in female patients and its presentation is unspecific in terms of symptoms, which can be compared to acute appendicitis, an abdominal mass, obstructive or gynecological symptoms, or urological manifestations, which are the least frequent. We present a 59-year-old female patient with an abdominal pain over 4 months located in the right iliac fossa; several complementary tests were performed such as a diagnostic laparoscopy, an exploratory laparotomy and an appendectomy. After these examinations, a histological diagnosis of appendiceal mucinous cystadenoma was made.
Subject(s)
Appendiceal Neoplasms , Pathological Conditions, Signs and Symptoms , Cystadenoma , LaparotomyABSTRACT
Introducción: La paracoccidioidomicosis, es una micosis endémica en diferentes países de latinoamérica, incluyendo zonas de Colombia, con manifestación clínica muy variada ya que es considerada una enfermedad que puede ser crónica y sistémica. Objetivos: Exponer la importancia del examen clínico-estomatológico en la detección de diferentes entidades en sistema estomatognático, y el manejo multidisciplinario de paracoccidioidomicosis oral y sistémica. Caso clínico: paciente masculino en sexta década de vida, el cual presenta glosalgia y dolor de región ocular. Clínicamente presenta lesión de tipo granulomatoso en bordes laterales de lengua con evolución de hace 1 año aproximadamente, el resultado de la biopsia es paracoccidioidomicosis, se inicia manejo multidisciplinario con medicamentos intravenosos y orales, luego de 10 meses presenta resolución de este. Conclusiones: un buen interrogatorio, análisis de cuadro clínico y exámenes complementarios, son claves para un diagnóstico temprano y tratamiento oportuno, preservando la vida del paciente, especialmente en infecciones oportunistas como la paracoccidioidomicosis.
Introdução: A paracoccidioidomicose é uma micose endêmica em diferentes países da América Latina, incluindo áreas da Colômbia, com manifestação clínica muito variada por ser considerada uma doença que pode ser crônica e sistêmica. Objetivos: Expor a importância do exame clínico-estomatológico na detecção de diferentes entidades do sistema estomatognático e no manejo multidisciplinar da paracoccidioidomicose oral e sistêmica. Caso clínico: paciente do sexo masculino na sexta década de vida, que apresentava glossalgia e dor na região ocular. Clinicamente apresenta lesão tipo granulomatosa nas bordas laterais da língua com evolução de aproximadamente 1 ano, resultado da biópsia é paracoccidioidomicose, inicia-se manejo multidisciplinar com medicações endovenosas e orais, após 10 meses resolve. Conclusões: um bom questionamento, análise do quadro clínico e exames complementares são fundamentais para o diagnóstico precoce e tratamento oportuno, preservando a vida do paciente, principalmente nas infecções oportunistas como a paracoccidioidomicose.
Introduction: Paracoccidioidomycosis is an endemic mycosis in different Latin American countries, including areas of Colombia, with a very varied clinical manifestation since it is considered a disease that can be chronic and systemic. Objectives: To expose the importance of the clinical-stomatological examination in the detection of different entities in the stomatognathic system, and the multidisciplinary management of oral and systemic paracoccidioidomycosis. Clinical case: male patient in the sixth decade of life, who presented glossalgia and pain in the ocular region. Clinically, it presents a granulomatous-type lesion on the lateral edges of the tongue with evolution of approximately 1 year ago, the result of the biopsy is paracoccidioidomycosis, multidisciplinary management is started with intravenous and oral medications, after 10 months it resolves. Conclusions: a good questioning, analysis of the clinical picture and complementary tests are key to early diagnosis and timely treatment, preserving the patient's life, especially in opportunistic infections such as paracoccidioidomycosis.
ABSTRACT
Introducción: Según el Ministerio de Salud las muertes por cáncer constituyen un cuarto del total de las defunciones registradas en Uruguay cada año. Objetivo: Conocer el perfíl epidemiológico de los pacientes diagnosticados de cáncer asistidos en el Hospital Departamental de Soriano. Material y métodos: Estudio observacional, retrospectivo y descriptivo que incluyó a los pacientes diagnosticados de cáncer asistidos en el Hospital Departamental de Soriano durante el 2022. Se mantuvo el anonimato de los pacientes en el análisis estadístico y se contó con la aprobación del Comité de Ética del Hospital de Clínicas. Resultados: Se incluyeron 113 pacientes nuevos; 53.1% fueron hombres, siendo la mediana de edad al diagnóstico de 69 años. Los 4 tumores más frecuentes para ambos sexos reunidos fueron: mama, próstata, pulmón y colo-recto; la distribución por estadio fue la siguiente: E IV 48.6% pacientes; EIII 22.5%; EII 26.5%; y EI 2.6%. En el 79.6% de las pacientes se contaba con la confirmación del diagnóstico mediante anatomía patológica. El tiempo entre el diagnóstico y el primer tratamiento oncológico fue ≤ 3 meses para el 88.2% de los pacientes. El total de los pacientes con EIV fueron contactados con la Unidad de Cuidados Paliativos. Únicamente el 15% de los casos fueron discutidos en Comité de Tumores. Conclusiones: Los datos analizados permitieron caracterizar el perfil epidemiológico del cáncer de los pacientes procedente de Soriano asistidos en el ámbito público y pueden contribuir a la implementación de políticas públicas orientadas a la prevención y por ende a la mejora en la asistencia pacientes asistidos.
Introduction: According to the Ministry of Health, cancer deaths constitute a quarter of the total deaths registered in Uruguay each year. Objective: To identify the epidemiological profile of patients diagnosed with cancer treated at the Departmental Hospital of Soriano. Materials and Methods: An observational, retrospective and descriptive study that included patients diagnosed with cancer attended at the Departmental Hospital of Soriano during 2022. The anonymity of the patients was maintained in the statistical analysis and approval was obtained from the Ethics Committee of the Hospital de Clínicas. Results: A total of 113 new patients were included; 53.1% were men, with a median age at diagnosis of 69 years old. The four most frequent tumors for both sexes were: breast, prostate, lung and colorectal; the distribution by stage was as follows: Stage IV 48.6% patients; Stage III 22.5%; Stage II 26.5%; and Stage I 2.6%. In 79.6% of the patients the diagnosis was confirmed by pathological anatomy. The time between diagnosis and first oncological treatment was ≤ 3 months for 88.2% of patients. The total number of patients with Stage IV were contacted by the Palliative Care Unit. Only 15% of the cases were discussed in the Tumor Committee. Conclusions: The data analyzed made it possible to characterize the epidemiological profile of cancer in patients from Soriano assisted in the public sector and may contribute to the implementation of public policies aimed at prevention and, therefore, at improving patient care.
Introdução: Segundo o Ministério da Saúde, as mortes por câncer constituem um quarto de todas as mortes registradas no Uruguai a cada ano. Objetivos: Conhecer o perfil epidemiológico dos pacientes diagnosticados com câncer atendidos no Hospital Departamental de Soriano. Material e Métodos: Estudo observacional, retrospectivo e descritivo que incluiu pacientes diagnosticados com câncer atendidos no Hospital Departamental de Soriano durante o ano de 2022. O anonimato dos pacientes foi mantido na análise estatística e foi aprovado pelo Comitê de Ética do Hospital de Clínicas. Resultados: foram incluídos 113 novos pacientes; 53,1% eram homens, com mediana de idade ao diagnóstico de 69 anos. Os 4 tumores mais frequentes para ambos os sexos combinados foram: mama, próstata, pulmão e colorretal; a distribuição por estágio foi a seguinte: E IV 48,6% pacientes; EIII 22,5%; EII 26,5%; EI 2,6%. Em 79,6% dos pacientes houve confirmação do diagnóstico pela patologia. O tempo entre o diagnóstico e o primeiro tratamento oncológico foi ≤ 3 meses para 88,2% dos pacientes. Todos os doentes com DIV foram contactados com a Unidade de Cuidados Paliativos. Apenas 15% dos casos foram discutidos no Comitê de Tumores. Conclusões: Os dados analisados ââpermitiram caracterizar o perfil epidemiológico do câncer em pacientes de Soriano atendidos na esfera pública e podem contribuir para a implementação de políticas públicas voltadas para a prevenção e, consequentemente, para a melhoria na assistência aos pacientes atendidos.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Neoplasms/epidemiology , Prostatic Neoplasms/epidemiology , Breast Neoplasms/epidemiology , Colorectal Neoplasms/epidemiology , Retrospective Studies , Risk Factors , Sex Distribution , Octogenarians , Sociodemographic Factors , Nonagenarians , Lung Neoplasms/epidemiologyABSTRACT
Introdução: Hipofosfatasia é um distúrbio metabólico que afeta a mineralização óssea e dentária, causada por mutações no gene ALPL, levando à deficiência enzimática da fosfatase alcalina tecido não-específica. A forma adulta caracteriza-se por fraturas atípicas do fêmur, osteomalácia, osteoporose, grave osteoartropatia, condrocalcinose e artralgia. Objetivo: Demonstrar desafios diagnósticos relacionados à hipofosfatasia através do relato de dois casos. Paciente 1: feminino, 59 anos, encaminhada para avaliação clínica devido às fraturas patológicas de difícil consolidação e osteoporose generalizada de causa genética. Relata perda dentária precoce da arcada superior, fraturas na coluna, em ombro esquerdo e no fêmur. Atualmente, queixa-se de dor crônica intensa, com uso de múltiplos medicamentos. Achados clínicos, laboratoriais e radiológicos foram compatíveis com o diagnóstico de hipofosfatasia. Paciente 2: masculino, 31 anos, filho da paciente 1, encaminhado para avaliação clínica por fratura patológica precoce em fêmur esquerdo e osteoporose não esclarecida. Atualmente relata dor e claudicação importante em membro inferior esquerdo, associado à lombalgia crônica. Confirmação do diagnóstico de hipofosfatasia por exames laboratoriais e radiológicos e sequenciamento do gene ALPL, aliados ao diagnóstico da sua genitora. Discussão: Hipofosfatasia é uma doença rara de herança autossômica dominante e recessiva. Pacientes acometidos apresentam fraturas constantes, densidade mineral óssea baixa, cicatrização óssea deficitária. É comum a hipofosfatasia ser diagnosticada erroneamente como osteopenia e/ou osteoporose primária, acarretando prejuízos ao paciente. Ressalta-se a importância da história clínica completa e dos antecedentes familiares a fim de se obter um diagnóstico precoce, garantindo, por sua vez, o adequado acompanhamento e manejo terapêutico (AU)
Introduction: hypophosphatasia is a metabolic disorder affecting bone and tooth mineralization, caused by mutations in the ALPL gene leading to enzymatic deficiency of tissue non-specific alkaline phosphatase. The adult form is characterized by atypical femur fractures, osteomalacia, osteoporosis, severe osteoarthropathy, chondrocalcinosis, and arthralgia. Objective: to demonstrate diagnostic challenges related to hypophosphatasia through the report of two cases. Patient 1: female, 59 years old, referred for clinical evaluation due to pathological fractures of difficult consolidation and generalized osteoporosis of genetic cause. She reports early tooth loss in the upper arch, fractures in the spine, left shoulder and femur. Currently, he complains of severe chronic pain, with use of multiple medications. Clinical, laboratory, and radiological findings were compatible with the diagnosis of hypophosphatasia. Patient 2:male, 31 years old, son of patient 1, referred for clinical evaluation due to an early pathological fracture in the left femur and unclear osteoporosis. He currently reports pain and significant claudication in the left lower limb, associated with chronic low back pain. Confirmation of the diagnosis of hypophasatasia by laboratory and radiological tests and sequencing of the ALPL gene combined with the diagnosis of his mother. Discussion: hypophosphatasia is a rare disease of autosomal dominant and recessive inheritance. Affected patients have constant fractures, low bone mineral density, and impaired bone healing. It is common for hypophosphatasia to be misdiagnosed as osteopenia and/or primary osteoporosis, which can be harmful to the patient. The importance of a complete clinical history and family history is emphasized in order to obtain an early diagnosis, ensuring adequate follow-up and therapeutic management (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Osteoporosis , Bone Diseases, Metabolic , Alkaline Phosphatase , Chronic Pain , Fractures, Spontaneous , Hypophosphatasia/diagnosisABSTRACT
OBJECTIVES: To investigate the correlationsbetween forkhead box D1 (FOXD1) expressionand clinicopathological characteristics of bladdercancer and influence on the biological behaviors ofbladder cancer cells. METHODS: The overall survival rate of 87 bladdercancer patients was evaluated to explore the predictivevalue of FOXD1. The expressions of FOXD1 in 87 bladdercancer tissues and 26 adjacent tissues were measuredthrough immunohistochemistry, and the correlationsbetween FOXD1 expression and clinicopathologicalcharacteristics of patients were analyzed. FOXD1 mimicand FOXD1 siRNA were mixed and transferred intoT24 cells to construct FOXD overexpression and knockdowncell lines. Cell counting kit-8, wound-healing andTranswell migration assays were performed to detectcell proliferation, migration and invasion. RESULTS: Prediction using bioinformatics websiteshowed that FOXD1 was highly expressed inbladder cancer tissues. The overall survival rate wassignificantly lower in bladder cancer patients withhigh FOXD1 expression than that in those with lowexpression (Psignificantly higher in bladder cancer tissues thanthat in adjacent tissues. The expression of FOXD1in bladder cancer tissues had no significant differencesamong patients with different gender, agesand tumor sizes, but significant differences amongthose with different tumor numbers, clinical stagesand histological grades (PNC group, the proliferation, migration and invasionof bladder cancer cells were significantly promotedin FOXD1 group and suppressed in si-FOXD1group (PCONCLUSIONS: FOXD1 is highly expressed in bladdercancer tissues and cells, being closely associatedwith the development and progression of bladder cancer.It facilitates the proliferation, migration and invasionof cells and carcinogenesis. FOXD1 may be a newtarget for bladder cancer therapy.
OBJETIVOS: Investigar la correlaciónentre la expresión de Forkhead Box D1 (FOXD1) y lascaracterísticas clínico patológicas del cáncer de vejigay su influencia en el comportamiento biológico de lascélulas tumorales.MÉTODOS: Se evaluó la supervivencia global de 87pacientes con cáncer de vejiga para explorar el valorpredictivo de FOXD1. La expresión de FOXD1 en 87 tejidostumorales y 26 tejidos adyacentes fueron evaluadoscon inmunohistoquímica y se analizaron las correlacionesentre FOXD1 y las características clínico-patológicas.FOXD1 mimic y FOXD1 siARN fueron mezclados ytransferidos a células T24 para crear la sobreexpresiónFOXD y causar un knockdown en las líneas celulares. Seutilizaron los ensayos Cell counting kit-8, wound-healingand Transwell migration para detectar la proliferacion,migración e invasion celular. RESULTS: La predicción obtenida con el uso de lapágina web bioinformatics mostró que FOXD1 estabaaltamente expresado en tejidos tumorales vesicales.La supervivencia global fue significativamente másbaja en pacientes con cáncer de vejiga con alta expresiónde FOXD1 que aquellos con baja expresión(Pmás alta en tejidos con cáncer de vejiga queen los tejidos adyacentes. La expresión de FOXD1 entejidos con cáncer de vejiga no presentó diferenciassignificativas en relacion al género, edad y tamañotumoral de los pacientes, pero sí presentó diferenciassignificativas entre el número de tumores, el estadioclínico y el grado histológico (Pcon el grupo NC, la proliferación, migración e invasionde las células tumorales fueron significativamentepromovidas en el grupo FOXD1 y suprimidasen el grupo si-FOXD1 (PCONCLUSIONS: FOXD1 está íntimamente asociadoal desarrollo y progresión del cáncer de vejiga al encontrarsealtamente expresado en las células del tejidotumoral. Facilita la proliferación, migración e invasióncelular en la carcinogénesis. FOXD1 podría ser unanueva diana para el tratamiento del cáncer de vejiga.
Subject(s)
Urinary Bladder Neoplasms , Cell Line, Tumor , Cell Proliferation/genetics , Female , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Gene Expression Regulation, Neoplastic , Humans , Male , Urinary Bladder Neoplasms/geneticsABSTRACT
Abstract Bone metastases may evolve with events (pain, fractures and compression) that the orthopedic surgeon will encounter regardless of his subspecialty. Accumulated surgical knowledge is predictive for the prevention of impending fractures, as well as of pathological fractures. We will present a guide to properly evaluate and conduct a patient with bone implant for surgeons who are not specialists in this area.
Resumo As metástases ósseas podem evoluir com eventos (dor, fraturas e compressão) com os quais o cirurgião ortopédico irá se depararar independentemente da sua subespecialidade. Os conhecimentos cirúrgicos acumulados são predicativos para a prevenção de fraturas iminentes, assim como de fraturas patológicas. Apresentaremos um guia para avaliar e conduzir de forma adequada um paciente com implante ósseo para cirurgiões que não sejam especialistas na área.
Subject(s)
Humans , Bone Neoplasms/therapy , Carcinoma/therapy , Fractures, Bone/prevention & control , Fractures, Bone/therapy , Neoplasm Metastasis/therapyABSTRACT
OBJECTIVES: To investigate the correlations between forkhead box D1 (FOXD1) expression and clinicopathological characteristics of bladdercancer and influence on the biological behaviors ofbladder cancer cells.METHODS: The overall survival rate of 87 bladdercancer patients was evaluated to explore the predictivevalue of FOXD1. The expressions of FOXD1 in 87 bladdercancer tissues and 26 adjacent tissues were measuredthrough immunohistochemistry, and the correlationsbetween FOXD1 expression and clinicopathologicalcharacteristics of patients were analyzed. FOXD1 mimic and FOXD1 siRNA were mixed and transferred intoT24 cells to construct FOXD overexpression and knockdown cell lines. Cell counting kit-8, wound-healing andTranswell migration assays were performed to detectcell proliferation, migration and invasion. RESULTS: Prediction using bioinformatics website showed that FOXD1 was highly expressed inbladder cancer tissues. The overall survival rate wassignificantly lower in bladder cancer patients withhigh FOXD1 expression than that in those with lowexpression (P<0.001). The expression of FOXD1 wassignificantly higher in bladder cancer tissues thanthat in adjacent tissues. The expression of FOXD1in bladder cancer tissues had no significant differences among patients with different gender, agesand tumor sizes, but significant differences amongthose with different tumor numbers, clinical stagesand histological grades (P<0.05). Compared withNC group, the proliferation, migration and invasionof bladder cancer cells were significantly promoted in FOXD1 group and suppressed in si-FOXD1group (P<0.05).CONCLUSIONS: FOXD1 is highly expressed in bladder cancer tissues and cells, being closely associatedwith the development and progression of bladder cancer. It facilitates the proliferation, migration and invasion of cells and carcinogenesis. FOXD1 may be a newtarget for bladder cancer therapy. (AU)
OBJETIVOS: Investigar la correlaciónentre la expresión de Forkhead Box D1 (FOXD1) y lascaracterísticas clínico patológicas del cáncer de vejigay su influencia en el comportamiento biológico de lascélulas tumorales.MÉTODOS: Se evaluó la supervivencia global de 87pacientes con cáncer de vejiga para explorar el valorpredictivo de FOXD1. La expresión de FOXD1 en 87 tejidos tumorales y 26 tejidos adyacentes fueron evaluadoscon inmunohistoquímica y se analizaron las correlaciones entre FOXD1 y las características clínico-patológicas. FOXD1 mimic y FOXD1 siARN fueron mezclados ytransferidos a células T24 para crear la sobreexpresiónFOXD y causar un knockdown en las líneas celulares. Seutilizaron los ensayos Cell counting kit-8, wound-healing and Transwell migration para detectar la proliferacion, migración e invasion celular.RESULTS: La predicción obtenida con el uso de lapágina web bioinformatics mostró que FOXD1 estabaaltamente expresado en tejidos tumorales vesicales.La supervivencia global fue significativamente másbaja en pacientes con cáncer de vejiga con alta expresión de FOXD1 que aquellos con baja expresión(P<0.001). La expresión de FOXD1 fue significativamente más alta en tejidos con cáncer de vejiga queen los tejidos adyacentes. La expresión de FOXD1 entejidos con cáncer de vejiga no presentó diferenciassignificativas en relacion al género, edad y tamañotumoral de los pacientes, pero sí presentó diferenciassignificativas entre el número de tumores, el estadioclínico y el grado histológico (P<0.05). Comparadocon el grupo NC, la proliferación, migración e invasion de las células tumorales fueron significativamente promovidas en el grupo FOXD1 y suprimidasen el grupo si-FOXD1 (P<0.05).CONCLUSIONS: FOXD1 está íntimamente asociadoal desarrollo y progresión del cáncer de vejiga al encontrarse altamente expresado en las células del tejidotumoral. Facilita la proliferación, migración e invasióncelular en la carcinogénesis. FOXD1
Subject(s)
Humans , Male , Female , Middle Aged , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/metabolism , Forkhead Transcription Factors/metabolism , Gene Expression Regulation, Neoplastic , Survival Analysis , Predictive Value of Tests , Immunohistochemistry , Cell Movement , Cell ProliferationABSTRACT
RESUMO:Introdução: Hipofosfatasia é um distúrbio metabólico que afeta a mineralização óssea e dentária, causada por mutações no gene ALPL, levando à deficiência enzimática da fosfatase alcalina tecido não-específica. A forma adulta caracteriza-se por fraturas atípicas do fêmur, osteomalácia, osteoporose, grave osteoartropatia, condrocalcinose e artralgia. Objetivo: Demonstrar desafios diagnósticos relacionados à hipofosfatasia através do relato de dois casos. Paciente 1: feminino, 59 anos, encaminhada para avaliação clínica devido às fraturas patológicas de difícil consolidação e osteoporose generalizada de causa genética. Relata perda dentária precoce da arcada superior, fraturas na coluna, em ombro esquerdo e no fêmur. Atualmente, queixa-se de dor crônica intensa, com uso de múltiplos medicamentos. Achados clínicos, laboratoriais e radiológicos foram compatíveis com o diagnóstico de hipofosfatasia. Paciente 2: masculino, 31 anos, filho da paciente 1, encaminhado para avaliação clínica por fratura patológica precoce em fêmur esquerdo e osteoporose não esclarecida. Atualmente relata dor e claudicação importante em membro inferior esquerdo, associado à lombalgia crônica. Confirmação do diagnóstico de hipofosfatasia por exames laboratoriais e radiológicos e sequenciamento do gene ALPL, aliados ao diagnóstico da sua genitora. Discussão: Hipofosfatasia é uma doença rara de herança autossômica dominante e recessiva. Pacientes acometidos apresentam fraturas constantes, densidade mineral óssea baixa, cicatrização óssea deficitária. É comum a hipofosfatasia ser diagnosticada erroneamente como osteopenia e/ou osteoporose primária, acarretando prejuízos ao paciente. Ressalta-se a importância da história clínica completa e dos antecedentes familiares a fim de se obter um diagnóstico precoce, garantindo, por sua vez, o adequado acompanhamento e manejo terapêutico. (AU)
ABSTRACT: Introduction: hypophosphatasia is a metabolic disorder affecting bone and tooth mineralization, caused by mutations in the ALPL gene leading to enzymatic deficiency of tissue non-specific alkaline phosphatase. The adult form is characterized by atypical femur fractures, osteomalacia, osteoporosis, severe osteoarthropathy, chondrocalcinosis, and arthralgia. Objective: to demonstrate diagnostic challenges related to hypophosphatasia through the report of two cases. Patient 1: female, 59 years old, referred for clinical evaluation due to pathological fractures of difficult consolidation and generalized osteoporosis of genetic cause. She reports early tooth loss in the upper arch, fractures in the spine, left shoulder and femur. Currently, he complains of severe chronic pain, with use of multiple medications. Clinical, laboratory, and radiological findings were compatible with the diagnosis of hypophosphatasia. Patient 2:male, 31 years old, son of patient 1, referred for clinical evaluation due to an early pathological fracture in the left femur and unclear osteoporosis. He currently reports pain and significant claudication in the left lower limb, associated with chronic low back pain. Confirmation of the diagnosis of hypophasatasia by laboratory and radiological tests and sequencing of the ALPL gene combined with the diagnosis of his mother. Discussion: hypophosphatasia is a rare disease of autosomal dominant and recessive inheritance. Affected patients have constant fractures, low bone mineral density, and impaired bone healing. It is common for hypophosphatasia to be misdiagnosed as osteopenia and/or primary osteoporosis, which can be harmful to the patient. The importance of a complete clinical history and family history is emphasized in order to obtain an early diagnosis, ensuring adequate follow-up and therapeutic management. (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Osteoporosis , Alkaline Phosphatase , Fractures, Spontaneous , Hypophosphatasia/diagnosisABSTRACT
INTRODUCTION: The phosphaturic mesenchymal tumour (PMT) is a very uncommon cause of oncogenic osteomalacia (OO), which is a paraneoplastic syndrome with severe clinical osteomalacia. The PMT is a neoplasia that produces the fibroblast growth factor FGF23, resulting in reduced proximal tubular phosphate reabsorption leading to hyperphosphaturia and hypophosphatemia. Our aim is to present our experience and complications in diagnosis and treatment of PMT in three patients. MATERIAL AND METHODS: We propose an observational, descriptive and retrospective study of three cases of OO secondary to PMT found in our database of bone and soft tissue tumours. The inclusion criteria were: symptoms related with OO, presence of hyperphosphaturic hypophosphatemia, elevated levels of FGF23 in blood and pathological diagnosis of PMT. RESULTS: In all cases, the disease showed asthenia, non-specific bone pain, progressive functional weakness, and pathological fractures. The average delay time in diagnosis was 7 years. All presented with hyperphosphaturic hypophosphatemia, elevated levels of alkaline phosphatase as well as FGF23. The use of Octreoscan and PET-CT were essential to find the producing tumour and its subsequent biopsy. Treatment was surgery in two cases and one case was treated by CT-guided cryotherapy with neurophysiological control. Once the surgery was performed, the blood parameters normalized. There is no recurrence. CONCLUSIONS: Phosphaturic mesenchymal tumor is a very rare entity as part of bone and soft tissue tumors, it may occur in both tissues. The phosphate-calcium homeostasis is altered due to high serum levels of FGF23 because of PMT. Delay in diagnosis is usual, leading to renal and skeletal comorbidities. To avoid this, knowledge of this entity together with high diagnostic suspicion are critical. Surgical treatment leads to normalization of serum levels and systemic symptoms.
ABSTRACT
Objetivo: Describir las principales características socio-demográficas y epidemiológicas, de las pacientes con tumores de ovarios. Métodos: Estudio descriptivo, transversal, con una población de 133 pacientes que acudieron a la consulta de Ginecología Oncológica, del Servicio Oncológico Hospitalario del IVSS, entre julio de 2016 y julio de 2017,con diagnóstico de tumores de ovarios, donde solo 24cumplieron con los criterios de inclusión. Resultados: Mayor procedencia Estado Miranda con 42%. La raza mestiza 46%.El promedio de edad 48,33 años. Menarquia promedio 12,29años. Sexarquia promedio de 19,14 años. Parejas sexuales entre 1-2, 46%. Antecedentes obstétricos: 2,5 gestaciones. Anticonceptivos orales 21%. Dispositivos intrauterinos en 21%.Hábito tabáquico 29%. Síntomas en el 83% (58% aumento de volumen abdominal) con evolución de 4,05 meses. 63%tumores benignos (cistoadenoma mucinoso con 46%), 33%tumores malignos (adenocarcinoma endometroide con 37%)y 4% tumor borderline (atípicamente proliferativo), el tipo(mucinoso). Según la clasificación FIGO estadio 1C y 3C con38% respectivamente. La lateralidad predominante lado derecho(54%). El promedio del tamaño fue de 17,60 cm. Conclusión: Las características socio-demográficas, epidemiológicas y clínico-patológicas, determinan el manejo adecuado de los tumoresde ovarios, por lo que deben ser investigadas a fondo, y deesta manera, ofrecer el mejor tratamiento individualizado a laspacientes(AU)
Objective: To describe the main socio-demographic and epidemiological characteristics of patients with ovarian tumors. Methods: Descriptive, cross-sectional study, with a population of 133 patients who attended the Oncology Gynecology clinic of the Hospital Oncology Service of the IVSS, between July 2016 and July 2017, with diagnosis of ovarian tumors, where only 24 complied with the inclusion criteria. Results: Of the 133 patients who attended the Oncology Gynecology clinic with a diagnosis of ovarian tumors, only 24 patients met the inclusion criteria. Highest origin Miranda State with 42%. The 46% mixed race. The average age 48.33 years. Average menarche 12.29 years. Average sexarchy of 19.14 years. Sexual couples between 1-2, 46%. Obstetric history: 2.5 pregnancies. Oral contraceptives 21%. Intrauterine devices in 21%. Smoking habit 29%. Symptoms in 83% (58% increase in abdominal volume) with evolution of 4.05 months. 63% benign tumors (mucinous cystadenoma with 46%), 33% malignant tumors (endometroid adenocarcinoma with 37%) and 4% borderline (atypically proliferative), the type (mucinous). According to the FIGO stage 1C and 3C classification with 38% respectively. The predominant laterality on the right side (54%). The average size was 17.60 cm. Conclusion: The socio-demographic, epidemiological and clinical-pathological characteristics determine the proper management of ovarian tumors, so they must be thoroughly investigated, and thus offer the best individualized treatment to patients(AU)
Subject(s)
Humans , Female , Adult , Middle Aged , Ovarian Neoplasms/epidemiology , Contraceptives, Oral , Intrauterine Devices , Ovary , Menarche , Cross-Sectional Studies , Gynecology , NeoplasmsABSTRACT
ABSTRACT BACKGROUND: Clinical guidelines are available to steer decisions regarding diagnosis, management and treatment of gastrointestinal disorders. Despite this, variations in physician's practices regarding gastroesophageal reflux disease (GERD) symptoms are well described in the literature. OBJECTIVE: To describe practices of physicians from different specialties on the management of patients with typical symptoms of GERD (heartburn and regurgitation) in a Brazilian sample. METHODS: National online survey enrolling a sample of general practitioners, gastroenterologists, cardiologists and otolaryngologists. The survey was conducted from August 6th to September 12th, 2018. Subjects answered a structured questionnaire addressing variables regarding physicians' profile (age, sex, specialty, practice setting, years in practice, type of medical expense reimbursement), their patients characteristics and prescribing behaviors. RESULTS: The final weighted sample was comprised of 400 physicians, 64% male, with an average of 15 years of experience. Physicians' estimates of gastroesophageal symptoms prevalence among their pool of patients was 37.6% for the total sample, reaching 70.3% among gastroenterologists. The medical specialty with lower average percentage of patients presenting gastroesophageal symptoms was otolaryngology (24.5%). Physicians reported that they request ancillary tests for 64.5% of patients with GERD typical symptoms. The most common diagnostic test was endoscopy (69.4%), followed by video nasolaryngoscopy (16.6%). The percentage of patient to whom endoscopy is performed was significantly higher among gastroenterologists and general practitioners as compared to otolaryngologists and cardiologists, while video nasolaryngoscopy is markedly more frequent among otolaryngologists. In terms of therapeutic options, the most frequently reported strategy was lifestyle modifications followed by proton pump inhibitors. CONCLUSION: Overall patients' profile and patterns of GERD diagnosis and management seem different between gastroenterologists, general practitioners, otolaryngologists, and cardiologists. Clinical guidelines should address this variability and include other medical specialties besides gastroenterologists in their scope.
RESUMO CONTEXTO: Diretrizes clínicas estão disponíveis para orientar decisões sobre diagnóstico, manejo e tratamento de desordens gastrointestinais. Apesar disso, variações nas práticas relacionadas aos sintomas de doença do refluxo gastroesofágico (DRGE) são observadas na literatura. OBJETIVO: Descrever os conhecimentos e práticas relacionados ao manejo de pacientes com sintomas típicos de DRGE (pirose e regurgitação) em uma amostra brasileira de médicos de especialistas e não especialistas. MÉTODOS: Inquérito nacional online investigando a conduta frente ao diagnóstico de DRGE em uma amostra de médicos generalistas, gastroenterologistas, cardiologistas e otorrinolaringologistas. O inquérito foi conduzido entre 6 de agosto e 12 de setembro de 2018. Os sujeitos responderam a um questionário estruturado avaliando variáveis relacionadas ao perfil dos médicos (idade, sexo, especialidade, contexto de prática, anos de experiência, tipo de reembolso de despesas médicas), características dos pacientes e comportamentos de prescrição. RESULTADOS: A amostra final ponderada foi composta por 400 médicos, 64% homens, com um tempo médio de experiência de 15 anos. A estimativa dos médicos a respeito da prevalência de sintomas gastroesofágicos entre seus pacientes foi de 37,6% para a amostra total, alcançando 70,3% entre gastroenterologistas. A especialidade médica com menor percentual de pacientes apresentando sintomas gastroesofágicos foi otorrinolaringologia (24,5%). Os médicos requisitaram exames complementares em 64,5% dos pacientes com sintomas típicos de DRGE. O exame diagnóstico mais frequente foi endoscopia (69,4%), seguida de nasolaringoscopia (16,6%). O percentual de pacientes nos quais uma endoscopia é realizada é significativamente maior entre gastroenterologistas e médicos generalistas, quando comparado a otorrinolaringologistas e cardiologistas, enquanto nasolaringoscopia é marcadamente mais frequente entre otorrinolaringologistas. Em termos de opções terapêuticas, a estratégia mais frequentemente reportada foi modificações no estilo de vida, seguida de inibidores da bomba de prótons. CONCLUSÃO: De modo geral, o perfil de pacientes e os padrões de diagnóstico e manejo de DRGE parecem diferir entre gastroenterologistas, médicos generalistas, otorrinolaringologistas e cardiologistas. Diretrizes clínicas devem abordar esta variabilidade e incluir outras especialidades médicas além de gastroenterologistas em seu escopo.
Subject(s)
Humans , Male , Female , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/therapy , Physicians , Practice Patterns, Physicians' , Brazil , Surveys and Questionnaires , Proton Pump Inhibitors/therapeutic useABSTRACT
RESUMEN Introducción: El íleo biliar es una patología poco frecuente caracterizada por obstrucción mecánica intestinal debido a la impactación de un cálculo biliar dentro del tracto gastrointestinal, caracterizado por la tríada de Rigler, se observa en pacientes de edad avanzada con antecedentes de colelitiasis o colecistitis, por la existencia de una fístula bilioentérica. Se asocia a alta morbilidad y mortalidad. Sus síntomas y signos en su mayoría son inespecíficos y su diagnóstico se basa en un enfoque radiológico. Si bien la cirugía abierta ha sido el pilar del tratamiento, recientemente se han empleado otros enfoques, incluyendo cirugía laparoscópica y litotripsia. Caso clínico:Paciente femenino de 100 años de edad con cuadro de dolor abdominal, náusea y vómito de varios días de evolución. El diagnóstico fue realizado por tomografía computarizada. Conclusión: El íleo biliar es una entidad clínica de difícil diagnóstico. El uso de técnicas de imagen puede mejorar la precisión diagnóstica y la toma de recursos terapéuticos. Palabras claves: Obstrucción Intestinal; Cálculos Biliares; Condiciones Patológicas, Signos y Síntomas; Tomografía Computarizada por Rayos X; Litotricia; Laparoscopía
ABSTRACT Introduction: Gallstone ileus is a rare pathology characterized by mechanical intestinal obstruction due to the impaction of a gallstone inside the gastrointestinal tract, characterized by the Rigler triad, it is observed in elderly patients with a history of cholelithiasis or chole-cystitis, due to the existence of a bilioenteric fistula. It is associated with high morbidity and mortality. Its symptoms and signs are mostly nonspecific and its diagnosis is based on a radiological approach. Although open surgery has been the mainstay of treatment, other approaches have recently been used, including laparoscopic surgery and lithotripsy. Clinical case: 100 year-old female patient, with ab-dominal pain, nausea and vomiting that lasted several days of evolution. The diagnosis was made by computed tomography. Conclusion: Gallstone ileus is a clinical entity difficult to diagnose. The use of imaging techniques can improve the diagnostic accuracy and the taking of therapeutic resources. Keywords: Obstrucción Intestinal; Cálculos Biliares; Condiciones Patológicas, Signos y Síntomas; Tomografía Computarizada por Rayos X; Litotricia; Laparoscopía
Subject(s)
Humans , Female , Aged, 80 and over , Gallstones , Tomography, X-Ray Computed , Cholecystitis , Lithotripsy , Laparoscopy , FistulaABSTRACT
RESUMEN Introducción: los niveles de presión arterial por encima de las cifras normales aumentan el riesgo de padecer enfermedades cardiovasculares y cerebrales. Las complicaciones ocasionadas por las crisis hipertensivas son muy peligrosas y a menudo fatales. Es de suma importancia conocer bien sus características clínicas para tratar de contrarrestar su evolución. Objetivo: describir el comportamiento de las crisis hipertensivas en 500 pacientes del Servicio de Emergencias del Hospital de Clínicas, en el período de enero a junio de 2018. Metodología: estudio descriptivo y retrospectivo. Se utilizaron las hojas de recepción, acogida y clasificación de urgencias y las historias clínicas de pacientes ingresados con crisis hipertensivas. Se emplearon frecuencias absolutas y relativas (porcentaje) para resumir la información, y tablas para su presentación. Resultados: en el estudio predominó el sexo masculino, con 351 (70%) pacientes, y 149 (30%) de sexo femenino. El grupo etario en el que existió mayor predominio de pacientes (49%) fue el de 50-59 años de edad. Se observó un predominio de las urgencias hipertensivas con 399 (79,8%) pacientes, mientras que solo 101 (20,2%) pacientes desarrollaron emergencias hipertensivas. El órgano diana más frecuentemente dañado fue el cerebro en 43 (42,6%) pacientes con un accidente vascular cerebral, seguido por el síndrome coronario agudo en 34 (33,7%) pacientes. La alteración electrocardiográfica mas frecuente fue la hipertrofia del ventrículo izquierdo en 187 (37,4%) pacientes, y en segundo lugar se encontró el supradesnivel del ST, que se presentó en 111 (22,2%) pacientes. Conclusión: las complicaciones y los hallazgos más significativos en estos pacientes con crisis hipertensivas fueron los accidentes vasculares encefálicos y el síndrome coronario agudo, así como la hipertrofia del ventrículo izquierdo y la elevación del segmento ST dentro de las alteraciones electrocardiográficas.
ABSTRACT Introduction: Blood pressure levels above normal levels increase the risk of cardiovascular and cerebral diseases. Complications caused by hypertensive crises are very dangerous and often fatal. It is very important to know their clinical characteristics well to try to counteract their evolution. Objective: To describe the behavior of hypertensive crises in 500 patients of the Emergency Service of the Hospital de Clínicas, in the period from January to June 2018. Methodology: Descriptive and retrospective study. The reception and emergency classification sheets and the medical records of patients admitted with hypertensive crisis were used. Absolute and relative frequencies (percentage) were used to summarize the information, and tables for presentation. Results: In the study the male sex prevailed, with 351 (70%) patients, and 149 (30%) of female sex. The age group in which there was a greater prevalence of patients (49%) was 50-59 years old. A predominance of hypertensive urgencies was observed with 399 (79.8%) patients, while only 101 (20.2%) patients developed hypertensive emergencies. The most frequently damaged target organ was the brain in 43 (42.6%) patients with a stroke, followed by acute coronary syndrome in 34 (33.7%) patients. The most frequent electrocardiographic alteration was left ventricular hypertrophy in 187 (37.4%) patients, and in the second place was the ST elevation, which occurred in 111 (22.2%) patients. Conclusion: The most significant complications and findings in these patients with hypertensive crises were cerebrovascular accidents and acute coronary syndrome, as well as left ventricular hypertrophy and ST-segment elevation within electrocardiographic abnormalities.
ABSTRACT
BACKGROUND AND OBJECTIVES: The primary aim of this study is to assess the effect of ultrasoung-guided erector spinae block on postoperative opioid consumption after laparoscopic cholecystectomy. The secondary aims are to assess the effects of erector spinae plane block on intraoperative fentanyl need and postoperative pain scores. METHODS: Patients between 18-70 years old, ASA I-II were included in the study and randomly allocated into two groups. In Group ESP, patients received bilateral US-ESP with 40ml of 0.25% bupivacaine at the level of T7, while in Group Control, they received bilateral US-ESP with 40ml of saline before the induction of anesthesia. Then a standard general anesthesia procedure was conducted in both groups. NRS scores at the postoperative 15th, 30th, 60th minutes, 12th and 24th hours, intraoperative fentanyl need and total postoperative tramadol consumption were recorded. RESULTS: There were 21 patients in Group ESP and 20 patients in Group Control. Mean postoperative tramadol consumption was 100±19.2mg in Group ESP, while it was 143±18.6mg in Group Control (p<0.001). The mean intraoperative fentanyl need was significantly lower in Group ESP (p=0.022). NRS scores at the postoperative 15th, 30th min, 12th hour and 24th hour were significantly lower in ESP group (p<0.05). According to repeated measures analysis, NRS score variation over time was significantly varied between two groups (F[1,39]=24.061, p< 0.0005). CONCLUSIONS: Bilateral US-ESP block provided significant reduction in postoperative opioid consumption, intraoperative fentanyl need and postoperative pain scores of patients undergoing laparoscopic cholecystectomy.
